- Analysis
- Barani Krishnan
- 32
Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. The company manufactures veterinary drugs in injectable, powder, oral solution, topical solution, disinfectant, and other forms. It is also developing anticancer drugs and cancer pain-relieving agents for human health and life. In addition, the company also engages in clinical pathological experiment, test, and analysis activities. The company was formerly known as Korea Microbiological Laboratories Co., Ltd. and changed its name to Komipharm International Co., Ltd. in September 2004. The company was founded in 1972 and is headquartered in Siheung-Si, South Korea.
Metrics to compare | 041960 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship041960PeersSector | |
---|---|---|---|---|
P/E Ratio | 24.0x | −2.6x | −0.6x | |
PEG Ratio | 0.11 | 0.03 | 0.00 | |
Price/Book | 4.2x | 0.7x | 2.6x | |
Price / LTM Sales | 5.0x | 0.7x | 3.1x | |
Upside (Analyst Target) | - | 38.7% | 47.1% | |
Fair Value Upside | Unlock | 11.7% | 8.1% | Unlock |